Inclusion Compounds of Fumagillol Derivative or its Salt, and Pharmaceutical Compositions Comprising the Same
OwnerJae Hyun Kim, Su Kyung Lee +5inventors
InventorsJae Hyun Kim, Su Kyung Lee, Won Kyu Choi, Jong Lae Lim, Soon Kil Ahn, Hee Jong Shin, Chung Il Hong
Life of this patent
Estimating the term…
Abstract
The present invention relates to an inclusion compound of fumagillol derivative or its salt with hydroxypropyl-β-cyclodextrin or sulfobutylether-7-β-cyclodextrin, and pharmaceutical compositions comprising the same. The inclusion compound according to the present invention has superior water solubility and stability while exhibiting low toxicity, rendering it valuable as an anticancer agent or inhibitor of tumor metastasis.
Claims16
An inclusion compound of fumagillol derivative of the Formula 1 or its salt with hydroxypropyl-β cyclodextrin or sulfobutylether-7-β cyclodextrin,
- wherein,
- X is hydroxy, Y is halogen, or X and Y together forms oxirane ring;
- B is O or H2;
- and R1, R2, R3, R4 and R5 independently represent hydrogen, hydroxy, acetoxy, C1-C6 alkyl, C1-C6 alkoxy, amino, alkylamino, dialkylamino, aminoalkyl, alkylaminoalkyl, dialkylaminoalkyl, aminoalkoxy, alkylaminoalkoxy, dialkylaminoalkoxy, halogen, cyano, trifluoromethyl, nitro, formyl, acetamido, methyleneoxycarboxy, methylenedioxy or ethylenedioxy group, provided that R1, R2, R3, R4 and R5 cannot be hydrogen at the same time.
-9. (canceled)
-18. (canceled)
Dependencies are inferred from the claim text.